Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 6,018
- Price
- $38.48
- Value
- $231,546
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•71 filings
ELVN
Enliven Therapeutics, Inc.
Net sales of $11.8M over the last 3 months
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$11,792,432
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$76,858,634
12 distinct insiders
Highlighted alerts
8
91 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get ELVN insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ELVN overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
99
Voluntary view
P/S trades after deterministic checks
46
Administrative noise
Stored, never alerted
86
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 6,018
- Price
- $14.85
- Footnotes
- 4
The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026. Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU. This transaction was executed in multiple trades at prices ranging from $37.785 to $38.765. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The option, originally for 185,000 shares, vested as to one-fourth of the shares on February 13, 2025, and the remainder of the shares vest in 36 equal monthly installments thereafter.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 5,000
- Price
- $38.47
- Value
- $192,342
Garland J. Scott
Director
SaleAlert
- Shares
- 13,000
- Price
- $46.67
- Value
- $606,719
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 289
- Price
- $51.49
- Value
- $14,881
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 2,194
- Price
- $50.72
- Value
- $111,270
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 3,535
- Price
- $50.03
- Value
- $176,851
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 240
- Price
- $51.48
- Value
- $12,356
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 1,844
- Price
- $50.71
- Value
- $93,507
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 2,916
- Price
- $50.03
- Value
- $145,891
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 1,388
- Price
- $59.35
- Value
- $82,383
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 4,630
- Price
- $58.35
- Value
- $270,168
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 1,100
- Price
- $59.35
- Value
- $65,281
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 3,900
- Price
- $58.37
- Value
- $227,650
Derynck Mika K
Director
Sale 10b5-1
- Shares
- 158,795
- Price
- $60.21
- Value
- $9,561,587
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 123
- Price
- $53.87
- Value
- $6,626
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 2,638
- Price
- $53.38
- Value
- $140,823
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 2,564
- Price
- $52.32
- Value
- $134,143
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 369
- Price
- $51.48
- Value
- $18,997
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 324
- Price
- $49.97
- Value
- $16,191
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 63
- Price
- $53.92
- Value
- $3,397
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 2,184
- Price
- $53.42
- Value
- $116,669
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 2,063
- Price
- $52.39
- Value
- $108,085
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 459
- Price
- $51.55
- Value
- $23,660
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 231
- Price
- $50.05
- Value
- $11,563
Kunkel Lori Anne
Director
Sale 10b5-1
- Shares
- 5,889
- Price
- $50.84
- Value
- $299,421
Kunkel Lori Anne
Director
Sale 10b5-1
- Shares
- 4,111
- Price
- $49.98
- Value
- $205,482
ORBIMED ADVISORS LLC
10% owner
SaleAlert
- Shares
- 46,776
- Price
- $45.00
- Value
- $2,104,920
ORBIMED ADVISORS LLC
10% owner
SaleAlert
- Shares
- 787,024
- Price
- $45.38
- Value
- $35,715,149
ORBIMED ADVISORS LLC
10% owner
SaleAlert
- Shares
- 1,477
- Price
- $45.00
- Value
- $66,465
ORBIMED ADVISORS LLC
10% owner
SaleAlert
- Shares
- 24,846
- Price
- $45.38
- Value
- $1,127,511
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 1,238
- Price
- $44.75
- Value
- $55,397
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 3,401
- Price
- $43.86
- Value
- $149,179
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 1,379
- Price
- $42.79
- Value
- $59,001
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 1,133
- Price
- $44.74
- Value
- $50,694
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 2,599
- Price
- $43.87
- Value
- $114,018
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 1,268
- Price
- $42.83
- Value
- $54,305
ORBIMED ADVISORS LLC
10% owner
SaleAlert
- Shares
- 272,322
- Price
- $45.02
- Value
- $12,259,936
ORBIMED ADVISORS LLC
10% owner
SaleAlert
- Shares
- 9,086
- Price
- $45.02
- Value
- $409,052
Kunkel Lori Anne
Director
Sale 10b5-1
- Shares
- 354
- Price
- $35.82
- Value
- $12,680
Kunkel Lori Anne
Director
Sale 10b5-1
- Shares
- 1,867
- Price
- $35.36
- Value
- $66,012
Kunkel Lori Anne
Director
Sale 10b5-1
- Shares
- 7,779
- Price
- $34.28
- Value
- $266,659
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 223
- Price
- $41.21
- Value
- $9,189
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 1,302
- Price
- $40.25
- Value
- $52,402
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 3,475
- Price
- $39.53
- Value
- $137,381
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 2,441
- Price
- $48.06
- Value
- $117,303
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 2,419
- Price
- $47.39
- Value
- $114,635
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 140
- Price
- $45.81
- Value
- $6,414
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 40,000
- Price
- $35.10
- Value
- $1,404,024
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 5,000
- Price
- $27.76
- Value
- $138,800
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 10,129
- Price
- $30.19
- Value
- $305,827
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 29,871
- Price
- $30.02
- Value
- $896,811
Hohl Benjamin
CHIEF FINANCIAL OFFICER
SaleAlert
- Shares
- 10,000
- Price
- $29.58
- Value
- $295,839
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 45,000
- Price
- $26.17
- Value
- $1,177,862
Heyman Richard A.
Director
Sale 10b5-1
- Shares
- 1,230
- Price
- $26.18
- Value
- $32,196
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 5,000
- Price
- $29.04
- Value
- $145,219
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 14,509
- Price
- $26.90
- Value
- $390,285
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 5,491
- Price
- $26.37
- Value
- $144,814
Heyman Richard A.
Director
Sale 10b5-1
- Shares
- 718
- Price
- $26.96
- Value
- $19,354
Heyman Richard A.
Director
Sale 10b5-1
- Shares
- 512
- Price
- $26.46
- Value
- $13,547
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 243
- Price
- $28.50
- Value
- $6,926
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 48,057
- Price
- $27.98
- Value
- $1,344,837
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 50,000
- Price
- $29.13
- Value
- $1,456,715
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 41,198
- Price
- $24.90
- Value
- $1,025,863
Heyman Richard A.
Director
Sale 10b5-1
- Shares
- 4,285
- Price
- $25.00
- Value
- $107,125
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 33,802
- Price
- $24.92
- Value
- $842,474
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 7,500
- Price
- $20.13
- Value
- $150,962
Heyman Richard A.
Director
Sale 10b5-1
- Shares
- 8,015
- Price
- $25.04
- Value
- $200,656
Heyman Richard A.
Director
Sale 10b5-1
- Shares
- 1,620
- Price
- $25.00
- Value
- $40,500
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 5,000
- Price
- $16.84
- Value
- $84,206
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 1,705
- Price
- $21.78
- Value
- $37,134
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 4,958
- Price
- $20.76
- Value
- $102,939
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 492
- Price
- $23.09
- Value
- $11,361
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 12,008
- Price
- $22.30
- Value
- $267,794
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 12,500
- Price
- $21.82
- Value
- $272,739
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 613
- Price
- $17.94
- Value
- $10,995
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 6,054
- Price
- $17.35
- Value
- $105,039
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 12,500
- Price
- $22.08
- Value
- $276,025
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 12,500
- Price
- $21.33
- Value
- $266,654
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 6,667
- Price
- $20.10
- Value
- $133,993
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 3,250
- Price
- $20.40
- Value
- $66,291
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 3,700
- Price
- $20.06
- Value
- $74,228
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 4,000
- Price
- $20.25
- Value
- $81,005
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 2,800
- Price
- $20.03
- Value
- $56,084
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 1,500
- Price
- $20.03
- Value
- $30,045
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 1,000
- Price
- $20.25
- Value
- $20,250
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 2,130
- Price
- $20.02
- Value
- $42,634
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 4,870
- Price
- $19.11
- Value
- $93,063
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 5,000
- Price
- $19.09
- Value
- $95,473
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 6,667
- Price
- $20.24
- Value
- $134,957
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 3,250
- Price
- $20.63
- Value
- $67,039
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 7,500
- Price
- $20.01
- Value
- $150,099
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 1,517
- Price
- $20.00
- Value
- $30,343
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sale 10b5-1
- Shares
- 5,000
- Price
- $19.62
- Value
- $98,118
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 590
- Price
- $20.00
- Value
- $11,800
Kintz Samuel
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 10,393
- Price
- $20.02
- Value
- $208,106
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 405
- Price
- $18.93
- Value
- $7,667
Patel Anish
CHIEF OPERATING OFFICER
Sale 10b5-1
- Shares
- 6,262
- Price
- $18.20
- Value
- $113,949
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 65
- Price
- $21.30
- Value
- $1,385
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale 10b5-1
- Shares
- 3,185
- Price
- $20.45
- Value
- $65,119
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 6,018 | $38.48 | $231,546 | |
| Oct 19, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 5,000 | $38.47 | $192,342 | |
| Oct 01, 2026 | Garland J. Scott Director | Sale | 13,000 | $46.67 | $606,719 | |
| Sep 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 289 | $51.49 | $14,881 | |
| Sep 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 2,194 | $50.72 | $111,270 | |
| Sep 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 3,535 | $50.03 | $176,851 | |
| Sep 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 240 | $51.48 | $12,356 | |
| Sep 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 1,844 | $50.71 | $93,507 | |
| Sep 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 2,916 | $50.03 | $145,891 | |
| Aug 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 1,388 | $59.35 | $82,383 | |
| Aug 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 4,630 | $58.35 | $270,168 | |
| Aug 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 1,100 | $59.35 | $65,281 | |
| Aug 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 3,900 | $58.37 | $227,650 | |
| Aug 04, 2026 | Derynck Mika K Director | Sale | 158,795 | $60.21 | $9,561,587 | |
| Jul 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 123 | $53.87 | $6,626 | |
| Jul 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 2,638 | $53.38 | $140,823 | |
| Jul 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 2,564 | $52.32 | $134,143 | |
| Jul 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 369 | $51.48 | $18,997 | |
| Jul 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 324 | $49.97 | $16,191 | |
| Jul 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 63 | $53.92 | $3,397 | |
| Jul 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 2,184 | $53.42 | $116,669 | |
| Jul 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 2,063 | $52.39 | $108,085 | |
| Jul 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 459 | $51.55 | $23,660 | |
| Jul 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 231 | $50.05 | $11,563 | |
| Jul 06, 2026 | Kunkel Lori Anne Director | Sale | 5,889 | $50.84 | $299,421 | |
| Jul 06, 2026 | Kunkel Lori Anne Director | Sale | 4,111 | $49.98 | $205,482 | |
| Jun 22, 2026 | ORBIMED ADVISORS LLC 10% owner | Sale | 46,776 | $45.00 | $2,104,920 | |
| Jun 22, 2026 | ORBIMED ADVISORS LLC 10% owner | Sale | 787,024 | $45.38 | $35,715,149 | |
| Jun 22, 2026 | ORBIMED ADVISORS LLC 10% owner | Sale | 1,477 | $45.00 | $66,465 | |
| Jun 22, 2026 | ORBIMED ADVISORS LLC 10% owner | Sale | 24,846 | $45.38 | $1,127,511 | |
| Jun 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 1,238 | $44.75 | $55,397 | |
| Jun 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 3,401 | $43.86 | $149,179 | |
| Jun 17, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 1,379 | $42.79 | $59,001 | |
| Jun 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 1,133 | $44.74 | $50,694 | |
| Jun 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 2,599 | $43.87 | $114,018 | |
| Jun 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 1,268 | $42.83 | $54,305 | |
| Jun 15, 2026 | ORBIMED ADVISORS LLC 10% owner | Sale | 272,322 | $45.02 | $12,259,936 | |
| Jun 15, 2026 | ORBIMED ADVISORS LLC 10% owner | Sale | 9,086 | $45.02 | $409,052 | |
| Jun 05, 2026 | Kunkel Lori Anne Director | Sale | 354 | $35.82 | $12,680 | |
| Jun 05, 2026 | Kunkel Lori Anne Director | Sale | 1,867 | $35.36 | $66,012 | |
| Jun 05, 2026 | Kunkel Lori Anne Director | Sale | 7,779 | $34.28 | $266,659 | |
| May 18, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 223 | $41.21 | $9,189 | |
| May 18, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 1,302 | $40.25 | $52,402 | |
| May 18, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 3,475 | $39.53 | $137,381 | |
| Apr 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 2,441 | $48.06 | $117,303 | |
| Apr 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 2,419 | $47.39 | $114,635 | |
| Apr 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 140 | $45.81 | $6,414 | |
| Mar 25, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 40,000 | $35.10 | $1,404,024 | |
| Mar 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 5,000 | $27.76 | $138,800 | |
| Mar 10, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 10,129 | $30.19 | $305,827 | |
| Mar 09, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 29,871 | $30.02 | $896,811 | |
| Mar 06, 2026 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 10,000 | $29.58 | $295,839 | |
| Feb 17, 2026 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | 45,000 | $26.17 | $1,177,862 | |
| Feb 17, 2026 | Heyman Richard A. Director | Sale | 1,230 | $26.18 | $32,196 | |
| Feb 06, 2026 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $29.04 | $145,219 | |
| Jan 20, 2026 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 14,509 | $26.90 | $390,285 | |
| Jan 20, 2026 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 5,491 | $26.37 | $144,814 | |
| Jan 20, 2026 | Heyman Richard A. Director | Sale | 718 | $26.96 | $19,354 | |
| Jan 20, 2026 | Heyman Richard A. Director | Sale | 512 | $26.46 | $13,547 | |
| Jan 09, 2026 | Patel Anish CHIEF OPERATING OFFICER | Sale | 243 | $28.50 | $6,926 | |
| Jan 09, 2026 | Patel Anish CHIEF OPERATING OFFICER | Sale | 48,057 | $27.98 | $1,344,837 | |
| Jan 09, 2026 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 50,000 | $29.13 | $1,456,715 | |
| Jan 09, 2026 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 41,198 | $24.90 | $1,025,863 | |
| Jan 09, 2026 | Heyman Richard A. Director | Sale | 4,285 | $25.00 | $107,125 | |
| Jan 08, 2026 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 33,802 | $24.92 | $842,474 | |
| Jan 08, 2026 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 7,500 | $20.13 | $150,962 | |
| Jan 08, 2026 | Heyman Richard A. Director | Sale | 8,015 | $25.04 | $200,656 | |
| Jan 08, 2026 | Heyman Richard A. Director | Sale | 1,620 | $25.00 | $40,500 | |
| Dec 19, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $16.84 | $84,206 | |
| Dec 08, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 1,705 | $21.78 | $37,134 | |
| Dec 08, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 4,958 | $20.76 | $102,939 | |
| Nov 19, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 492 | $23.09 | $11,361 | |
| Nov 19, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 12,008 | $22.30 | $267,794 | |
| Nov 17, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 12,500 | $21.82 | $272,739 | |
| Nov 07, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 613 | $17.94 | $10,995 | |
| Nov 07, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 6,054 | $17.35 | $105,039 | |
| Oct 20, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 12,500 | $22.08 | $276,025 | |
| Oct 17, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 12,500 | $21.33 | $266,654 | |
| Oct 07, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 6,667 | $20.10 | $133,993 | |
| Sep 29, 2025 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 3,250 | $20.40 | $66,291 | |
| Sep 26, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 3,700 | $20.06 | $74,228 | |
| Sep 26, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 4,000 | $20.25 | $81,005 | |
| Sep 23, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 2,800 | $20.03 | $56,084 | |
| Sep 23, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 1,500 | $20.03 | $30,045 | |
| Sep 19, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 1,000 | $20.25 | $20,250 | |
| Sep 19, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 2,130 | $20.02 | $42,634 | |
| Sep 19, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 4,870 | $19.11 | $93,063 | |
| Sep 17, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 5,000 | $19.09 | $95,473 | |
| Sep 08, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 6,667 | $20.24 | $134,957 | |
| Aug 27, 2025 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 3,250 | $20.63 | $67,039 | |
| Aug 21, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 7,500 | $20.01 | $150,099 | |
| Aug 20, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 1,517 | $20.00 | $30,343 | |
| Aug 19, 2025 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $19.62 | $98,118 | |
| Aug 19, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 590 | $20.00 | $11,800 | |
| Aug 18, 2025 | Kintz Samuel PRESIDENT AND CEO | Sale | 10,393 | $20.02 | $208,106 | |
| Aug 07, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 405 | $18.93 | $7,667 | |
| Aug 07, 2025 | Patel Anish CHIEF OPERATING OFFICER | Sale | 6,262 | $18.20 | $113,949 | |
| Jul 28, 2025 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 65 | $21.30 | $1,385 | |
| Jul 28, 2025 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | 3,185 | $20.45 | $65,119 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.